Circulating angiogenesis-related biomarkers, such as VEGF-A, soluble VEGF receptor-2 (sVEGFR-2), and galectin-3, demonstrates clinical utility for early AF detection and risk stratification. Here, LGALS3 is linked to atrial fibrillation.